Astorg, a leading private equity firm, has acquired a majority stake in Solabia, a specialist company that develops natural and biotech-based ingredients used in cosmetics, skincare, nutrition, and pharmaceuticals. The deal is backed by a €600 million financing package led by Goldman Sachs and Arcmont Asset Management.
Solabia is known for creating innovative natural compounds that help brands make safer, cleaner, and more effective beauty and wellness products—especially as regulators and consumers increasingly push away from synthetic chemicals.
Why it matters:
This acquisition highlights growing investor interest in companies that blend biology and technology to deliver natural, high-performance ingredients. For consumers, it means more skincare and beauty products made with advanced natural science rather than harsh chemicals—reflecting a global shift towards sustainability and transparency in beauty.